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Abstract
Objective: This study was undertaken to analyze the prevalence and spectrum 
of atypical glandular cells to investigate its clinical significance in our 
population.
Study design: A 5 year retrospective review of atypical glandular cells 
diagnosed on ThinPrep pap test was performed.  AGC were reported in 40 
patients, who underwent colposcopy- directed biopsy, endocervical curettage 
and endometrial curettage to determine the cytological and histological 
correlations of AGC. 
Results: The prevalence of AGC was 0.2% out of 19836 patients. The patients 
age ranged from 29 to 81 years (mean age 49.4 years). Significant lesions 
were defined as Squamous Intraepithelial lesion (SIL), adenocarcinoma in 
situ (AIS) or invasive carcinoma. This included 2 invasive squamous cell 
carcinoma of the cervix, 2 high grade squamous intraepithelial lesions, 2 AIS, 
5 adenocarcinoma of the cervix, two of which had low grade and high grade 
squamous intraepithelial lesions one of which was consistent with metastastic 
colonic carcinoma and 5 endometrial adenocarcinoma, one of which was 








Conclusion: AGC were associated with clinically significant lesions in 40% 
of our cases.. Significant endocervical glandular lesions occurred in younger 
women whereas the older women had endometrial lesions.. Patients with 
AGC should be followed up for a substantial period despite initial negative 
histological findings. 
Keywords: The Bethesda system; Atypical glandular cells; ThinPrep Pap 
test; Adenocarcinoma.
1. INTRODUCTION
The Bethesda System (TBS) in 1988 introduced the term atypical glandular cells of 
undetermined significance (AGUS) as a diagnostic category for the endocervical 
or endometrial glandular cells that demonstrate nuclear atypia  appearing to 
exceed reactive or reparative changes but lacking unequivocal features of 
adenocarcinoma. [1]. In 2001 the classification of glandular abnormalities was 
significantly revised. The term AGUS has been eliminated and the glandular 
cell abnormalities are classified into three categories; atypical glandular cells 
(AGC) either endocervical, endometrial cells or ‘glandular cells’ “not otherwise 
specified” (AGC-NOS) and favor neoplasia (AGC-FN) and endocervical 
adenocarcinoma in situ (AIS) [2]. AGC is an uncommon cytological diagnosis 
occurs in approximately 0.18-0.74% of cervical smears [3]. On further evaluation 
50-85 percent of women with AGC will have no histological abnormalities [3]. 
Some studies have reported that the risk of premalignant and malignant conditions, 
ranging from 17-59 percent [4] The origin of benign, premalignant or malignant 
lesions that presents as atypical glandular cells varies with the age of the patient. 
Cervical pathology is more likely in younger women where as in older women the 
endometrium is the more likely origin of atypical glandular cells [5]. The AGC 
represents a wide variety of clinically benign lesions to clinically significant 
premalignant or malignant lesions. The benign lesions associated with AGC 
are chronic cervicitis, endometriosis, squamous metaplasia, tubal metaplasia, 
microglandular hyperplasia, pregnancy, previous cone biopsy, radiation and 
cervical polyps [6]. The clinically significant premalignant or malignant lesions 
include squamous cervical intraepithelial neoplasia (CIN), adenocarcinoma in 
situ (AIS) of the cervix, complex endometrial hyperplasia, malignancy of the 
lower and upper genital tracts and rarely abdominal or distant non reproductive 
organs [6] Over the past few decades the incidence of cervical adenocarcinoma 
in situ (AIS) and adenocarcinoma has been increasing [7]. Although the cervical 
cytology screening can be used to detect squamous lesions with a low sensitivity 
for glandular lesions, it offers the potential for the prevention of cervical 
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adenocarcinoma by detecting the precursor adenocarcinoma in situ (AIS) [8] 
and also enhances the opportunity to detect endometrial abnormalities in some 
cases. 
The purpose of our retrospective study was to analyze the prevalence and 
spectrum of atypical glandular cells to investigate its clinical significance in 
our local population. 
2. MATERIALS AND METHODS
2.1 Study Population
A retrospective computer based search system was carried out to identify 
all patients with the cytological diagnosis of atypical glandular cells on 
Thin Prep Pap tests over a period of five years from June 2005 to May 2010 
in the Cytology Unit, Pathology and Genetics Department, Dubai Hospital, 
UAE. A Total of 19,836 Thin Prep pap tests were obtained out of which 
60 were diagnosed as atypical glandular cells. Among the 60 patients, 
20 patients were excluded due to loss of tissue biopsy follow up. Forty 
patients had histological follow up with tissue biopsy and these constituted 
the study.
2.2 Specimen Preparation
Cervical cytology (Thin Prep) specimens were obtained by cervix brush and 
processed to make Thin Prep slides using an automated processor (Hologic, 
UK). The Thin Prep slides were fixed in 95% ethyl alcohol and stained by 
Papanicolaou stain. 
2.3 Data Analysis
The demographics and clinical data included the patient age, parity, 
menopausal status, use of hormone replacement therapy, use of oral 
contraceptives, symptoms, physical examination findings, history of 
previous abnormal cervical smears, history of cancer, previous cervical 
surgery and colposcopic findings and treatment. The method by which 
tissue was obtained for the histological evaluation varied and included 
endocervical biopsy, endocervical curettage, endometrial biopsy, 
endometrial curettage and cervical biopsy. In addition those patients who 
received other diagnostic or treatment procedures such as cone biopsy, loop 
electrosurgical excision procedure (LEEP), polypectomy and hysterectomy 
were also included in the study. We included both pre invasive and invasive 







intraepithelial lesion, squamous cell carcinoma, adenocarcinoma in situ, 
cervical adenocarcinoma, endometrial adenocarcinoma and cancer of other 
sites. 
3. CYTOLOGICAL DIAGNOSTIC INTERPRETATIONS
The Thin Prep pap slides of 40 patients initially diagnosed as atypical glandular 
cells were reviewed by a second blind screening and independently interpreted 
by two cytopathologists and a cytotechnologist. The cytological diagnosis of 
AGC were reclassified using TBS terminology as 
1) Atypical glandular cells (AGC-NOS), 
2) AGC-endocervical,
3) AGC-endometrial
4) AGC-favor neoplasm (FN),
5) Endocervical adenocarcinoma in situ (AIS)
6) Endocervical Adenocarcinoma, and 
7) Endometrial Adenocarcinoma.
The reviewer’s interpretations were tabulated. The cytological results were 
correlated with histological findings as the gold standard. 
3.2 Statistical Analysis
The analysis was performed on SPSS 20 statistical software. A correlation 
analysis evaluating chi-square and spearman rho was also used to find the 
histological correlates of the cytological smears reported as atypical glandular 
cells; which was found to be statistically significant. The overall sensitivity, 
specificity and the false positive rates were calculated.
4 RESULTS
A total of 19,836 cervical ThinPrep pap tests were obtained over a period of five 
years.  60 patients were reported as having the diagnosis of atypical glandular 
cells. Follow up histology was available for 40 patients with a prevalence of 
0.2% in our local population. The age of the patients ranged from 25 to 81 
years with a mean age of 49.4 years. 
From the forty patients thirty eight women (95%) were symptomatic and 
two women (5%) were asymptomatic.  Ten symptomatic women were presented 
with post-menopausal bleeding, three had perimenopausal bleeding, three had 
post coital bleeding and intermenstrual bleeding, six had menorrhagia (one 
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of which had intrauterine contraceptive device), two had prolonged periods, 
two had lower abdominal pain, five had previous abnormal smears, one had 
clinically suspicious cervix, one had cervical polyp, one had endometrial 
polyp, one had bulky cervix, one had uterine fibroid, one had vaginal discharge 
and one had a previous history of HPV genital infection. The remaining 2 
asymptomatic women had routine cervical screening. 
The forty women, who had subsequent histological evaluation, underwent 
the following clinical procedures with the number of patients in parenthesis: 
Endometrial biopsy (4), endometrial curettage (8), Endocervical biopsy 
(3), Endocervical curettage (4), cervical biopsy (5), Cone biopsy (2), Loop 
electrosurgical excision procedure (LEEP) (1), Polypectomy (7) and 
Hysterectomy (6). There was no uniform clinical evaluation. Some patients 
had more than one investigation.
Sixteen women (40%) from the study had histologically significant lesions 
in the tissue biopsy. Two women had cervical intraepithelial neoplasia (CIN-
3) (12. 5%), two had invasive squamous cell carcinoma (12.5%), two had 
adenocarcinoma in situ (AIS) (12.5%), five had endocervical adenocarcinoma 
(31.25%) one of which showed CIN-3, consistent with metastatic colonic 
adenocarcinoma  and another with HPV changes and CIN-I and five had 
Endometrial adenocarcinoma (31.25%) one of which was suspicious of breast 
carcinoma and  two were serous papillary. All these lesions were detected at 
follow up (1-24 months). Twenty four women (60%) had non neoplastic 
findings (32.5% benign and 27.5% negative) which included seven women 
with benign cervical & endometrial polyps one of which showed focal complex 
hyperplasia, two women with cervicitis and squamous metaplasia, two women 
with simple cystic hyperplasia of the endometrium, one woman with disordered 
proliferative endometrium, one woman with ectocervical chronic inflammation 
and granulation tissue and eleven women with no significant pathologic findings.
In our study, significant lesions occurred in 16 patients (40%) who had a mean 
age of 51.1 years. AGC endocervical origin was reported in 4 women with a mean 
age of 42.5 years and AGC endometrial origin in 5 women with a mean age of 
55.2 years. AIS reported in 2 women with a mean age of 45 years. AGC with low 
grade and high grade squamous lesions reported in 2 women with a mean age of 
55 years and AGC favor neoplasm in 3 women with a mean age of 57.7years.
The results of follow up histological tissue diagnosis and their relation 
to menopausal status were also studied. Among the 16 women 10 were 
premenopausal who had 2 high grade squamous intraepithelial lesions and 1 
had squamous cell carcinoma, 2 had adenocarcinoma in situ (AIS) and 4 had 
endocervical adenocarcinoma and 1 had endometrial carcinoma. The remaining 







Figure 1: Cytology AGC :Three dimentional cluster of cells with enlarged 
slightly hyperchromatic nuclei and slight pleomorphism infiltrated by 
neutrophils. Follow up biopsy showed benign endometrial polyp. (ThinPrep, x 
400, Papanicolaou stain).
Table I: Demonstrates the histologic findings and the clinical condi-
tion per age group.
Age Histologic findings Clinical condition







35-40 1 0 2 0 0 3 2 0 2 1 5
41-50 1 1 0 4 1 7 0 0 1 2 3
51-60 0 0 0 1 2 3 1 2 0 0 3
>60 0 1 0 0 2 3 2 3 0 0 5
Total 2 2 2 5 5 16 5 5 3 3 16
CIN: cervical intraepithelial neoplasia, SCC: squamous cell carcinoma, 
AIS: adenocarcinoma in-situ, EC: endocervical carcinoma, EM: endometrial 
carcinoma; Pre MB: premenopausal bleeding, Post MB: post menopausal 
bleeding, Prev.ABN: previously abnormal smear, Other: includes polyps and 
suspicious.
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endocervical carcinoma and 4 had endometrial carcinoma as shown by the 
histological diagnosis. Endometrial lesions occurred in older women (mean 
age= 61.2 n= 5). Cervical lesions occurred in younger women (mean age=42 
n=7). The youngest woman with AIS was 39 years and endometrial carcinoma 
was found in a 43 year old woman. AGC was diagnosed in almost all the age 
groups (29-81 years), which is also depicted in Table 1. 
The revised interpretation of the reviewers on the initially diagnosed cases 
as AGC is shown in Table 2. 
Figure 2 (A): Cytology: Adenocarcinoma,endocervical. Sheet and syncitial 
group of cells with crowded, overlapped and hyperchromatic nuclei and nucleoli  
showing high nuclear/ cytoplasmic ratio. (ThinPrep, Papanicolaou stain, x 400).
Figure 2(B): Histology: Follow up histology showed invasive 







The 40 Thin Prep Pap slides initially diagnosed as AGC was reviewed by 
two cytopathologists and a cytotechnologist. From the analysis it is found that 
the reviewers AGC diagnostic rate was 67.5%, 65% and 80% respectively. 
AGC interpretation of the three reviewers was retained for only 28 cases 
and 12 cases were downgraded to reactive/ negative. Of the 28 revised AGC 
cases 16 (57.14%) had significant histological lesions and the remaining 
(42.85%) showed benign and normal histological findings. The cytological 
interpretations of the 16 cases which had significant histological lesion were 
diagnosed by all the reviewers. No significant lesions were identified in the 
remaining 12 cases that were downgraded from AGC to reactive / negative and 
were consistently reported by all the three reviewers. Hence the false positive 
interpretation was 30%. The study showed 100% sensitivity, with a specificity 
of 42.85%. The positive predictive value was 57.1%. 
The reviewers found difficulty in some cases to differentiate whether the AGC 
were endometrial or endocervical in origin. A case of endometrial adenocarcinoma 
was reported as AGC by all the reviewers as they could not sub classify. The 
initial cytological diagnosis of Suspicious Adeno-squamous carcinoma was 
Table II: Summarises the revised interpretation of the reviewers on the 
initially diagnosed cases as AGC.
Reviewer AGCs Negative HSIL Favor 
neoplasm
AIS SCC Adeno 
carcinoma
Total
1 11 14 4 2 3  1 5 40
2 2 14 4 0 4 1 5 40 
3 21 8 4 5 2  0 0 40
AGCs: abnormal glandular cells, HSIL: high-grade squamous intraepithelial lesions, AIS: 
adenocarcinoma in-situ, SCC: squamous cell carcinoma. 








Cytology Positive 16 0 16
Negative 12 12 24 21.818* 0.702* <0.001
Total 28 12 40
(* significant at <0.001)
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reported as AGC and HSIL by the reviewers and the histology showed Invasive 
adenocarcinoma with severe dysplasia consistent with metastatic colonic 
adenocarcinoma. The correlation of cytology and histological results were found 
by using chi-square analysis and spearman’s rho, non-parametric correlation. The 
correlation rho is found to be significant indicating high association between the 
results. The cytological diagnosis can be predictive and conclusive.
DISCUSSION 
A typical glandular cells are an uncommon but important cytological diagnosis. 
The purpose of our retrospective study was to analyze the prevalence and 
spectrum of atypical glandular cells to investigate its clinical significance in 
our population on Thin Prep Pap test (liquid based cytology). 
The prevalence of AGC was 0.2% during the study period amounting to 40 
patients out of 19,836 patients was systematically reviewed over a period of five 
years. The results were in agreement with the literature occurring in approximately 
0.18-0.74% of cervical smears [9]. In this study 66.6% of patients with AGC had 
histological follow up. The follow-up rate was higher than the reported rate of 
22-58% in many studies [10-13]. The rate of clinically significant lesions was 
40 % on subsequent histological follow-up. This is in congruence with reported 
rates of 25-83% [14-15]; the result also stresses the importance of performing 
subsequent tissue biopsy. Follow up studies on patients with AGC have shown a 
wide spectrum of benign and clinically significant lesions. Despite the diagnosis 
of AGC, significant lesions consisted of both glandular and squamous lesions 
(including  adenocarcinoma in situ, invasive endocervical adenocarcinoma and 
endometrial adenocarcinoma and squamous lesions included invasive squamous 
cell carcinoma and high grade squamous intraepithelial lesion. Two of our 
patients were diagnosed as having endocervical adenocarcinoma along with low 
grade and high grade squamous intraepithelial lesions. This is in keeping with 
well recognized reports of such coexistence [16]. Benign lesions associated with 
AGC include polyps, chronic cervicitis, tubal metaplasia, cystic hyperplasia, 
disordered proliferation and granulation tissue [6]. 
The study also indicates that the age of the patient appears to be relevant while 
assessing the AGC smears. The origin of benign, premalignant or malignant 
lesions varied with the age of the patient [5]. Significant lesions occurred in 16 
women who had a mean age of 51.1 years. Cervical glandular lesions occurred 
in 7 women who had a mean age of 42 years and endometrial lesions occurred in 
5 women who had a mean age of 61.2years. This age distribution suggests that 
younger women are less likely has endometrial disorders [17]. In older women 
the atypical glandular cells are more likely endometrial in origin [5]. The results 







The squamous lesions are diagnosed approximately in 20-100% of AGC, 
much more than glandular neoplastic lesions [18]. From this study two cases 
which were interpreted in the initial review and reconcluded by the reviewers 
as AGC with HSIL turned out to be squamous cell carcinoma in histological 
follow up.  In such cases to distinguish between squamous and glandular 
lesions, immuno histochemistry stain for P63 can be helpful as it highlights 
only the squamous lesions [20]. 
In our study and analysis of the significant lesions, the majority of cases 
(62.5%) were glandular lesions mostly from the female genital tract. This may 
be explained by the fact that some cases which were initially under diagnosed 
as cases of adenocarcinoma and upon secondary review applying strict criteria 
(adherence to TBS), those cases were revised as adenocarcinoma. 
The study showed two cases with .histologic findings suggestive of metastatic 
colonic and breast carcinoma. Histologically proven adenocarcinoma cases, 
mostly were primary tumors but also included metastatic adenocarcinoma of 
other sites such as colon and breast [7], which is in accordance with other 
research findings. Primary and metastatic adenocarcinomas appear to be 
indistinguishable on cytological material. It appears in the study that post-
menopausal condition and abnormal vaginal bleeding are associated with 
endometrial or glandular disease [19], as is shown in other studies. The study 
also indicates that an endometrial evaluation is warranted in patients above 35 
years and older [20], because the majority of glandular lesions of endometrial 
origin occurred in post-menopausal women. 
The cervical glandular and squamous neoplasia is etiologically linked 
to human papilloma virus (HPV) [21].  HPV DNA testing was not available 
during the study period. Testing for high risk HPV with AGC cytology would 
also prove to be effective. Associated studies have shown that 24-45% of AGC 
cases test positive for high risk HPV DNA [22].
Patients with AGC diagnosis, in spite of negative tissue biopsy findings 
may require longer duration of follow up to increase the diagnostic accuracy. 
Among the significant lesions detected during the follow up in our patients 
were diagnosed in 1-24 months after the initial diagnosis of AGC. In our study 
one case cytologicaly interpreted AIS, revealed cervical polyp in the initial 
biopsy and AIS in the follow up of 12 months. Another woman had micro 
invasive adenocarcinoma in the follow up of 24 months. Clinically significant 
uterine lesions in 13% of women after a mean follow-up of 37 months [23] 
were also shown in other studies. 
AGC with previous abnormal smears totaled five cases which revealed 
1 invasive squamous cell carcinoma, 1 micro invasive adenocarcinoma, 1 
adenocarcinoma in situ, 1 high grade squamous intraepithelial lesion and 
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1 was negative for malignancy in the histological follow up. Hence repeat 
cervical smear testing should be included in the investigation for patients with 
AGC [24].
Among the 40 cases initially diagnosed as AGC, only 28 cases were retained 
as AGC by the three reviewers. The remaining 12 cases were interpreted as 
reactive/negative cytologically and with normal histological findings. The 
cytological interpretation of atypical glandular cells is poorly reproducible. In 
a study the poor reproducibility among the expert reviewers was reported by 
using smears originally classified  as  AGC[25].   Our high false positive smears 
were related to reactive atypia in patients with polyps and also in endometrial 
hyperplasia cases where endometrial cells appeared worrisome on cytological 
evaluation and may be the reason for overcall. The interpretative pitfalls could 
also be due to second blind screening without demographic profiling. 
This study showed clinically significant glandular lesions in 30% of 
patients with atypical glandular cells. There was good correlation between 
cytological and histological results of the significant lesions. The chi-square 
value also showed that there is significant correlation between the cytological 
–histological outcome.
There was no National screening program in our population, during 
the study period; therefore the cases were opportunistic or symptomatic 
analizations. When compared to other studies this study is very small and may 
not have significant statistical power.
The patients clinical information is important when interpreting atypical 
glandular cells. Adherence to interpretation criteria of the atypical glandular 
cells must be maintained to avoid overuse. A consensus diagnosis may help to 
improve diagnostic accuracy. While interpreting the Pap smear from a post-
menopausal woman a careful search for atypical glandular cells should be 
made to improve the diagnostic accuracy.
CONCLUSION
The prevalence of AGC in our study was 0.2% and its associated significant 
pathologic findings found in our population were similar to that of large 
institution based studies. The presence of atypical glandular cells in cervical 
smears may exhibit a spectrum of findings from benign or reactive changes 
to squamous or glandular malignant or pre malignant lesions. This review 
showed significant endocervical lesions occurred in younger women where 
as the older women had endometrial lesions. Patients with atypical glandular 
cells with the clinical presentation of abnormal vaginal bleeding and post 







at risk for clinically significant lesions should be followed up for a substantial 
period despite initial negative histological findings. 
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